COMBINATION CANCER THERAPY USING CHK INHIBITOR
Publication
EP4087563A1
Kind: A1
Mar 18, 2026
Applicants
Shanghai Huayu Biotechnology Co., Ltd.
Inventors
WU, Fan, WU, Zhanggui
IPC Classifications
A61K 31/404 20060101AFI20240222BHEP
A61K 31/405 20060101ALI20240222BHEP
A61K 31/4196 20060101ALI20240222BHEP
A61P 35/00 20060101ALI20240222BHEP
A61K 31/17 20060101ALI20240222BHEP
A61K 31/4745 20060101ALI20240222BHEP
A61K 31/495 20060101ALI20240222BHEP
A61K 31/501 20060101ALI20240222BHEP
A61K 31/5025 20060101ALI20240222BHEP
A61K 31/519 20060101ALI20240222BHEP
A61K 31/7068 20060101ALI20240222BHEP
A61K 33/243 20190101ALI20240222BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR